Intracavitary chemotherapy (Gliadel®) for recurrent esthesioneuroblastoma: Case report and review of the literature

Journal of Neuro-Oncology

Volumn 77, Issue 1, 2006, Pages 47-51

  Park, Michael C ^a   Weaver Jr , Charles E ^a   Donahue, John E ^c   Sampath, Prakash ^a,b  

^a RHODE ISLAND HOSPITAL   (United States)

^b ROGER WILLIAMS MEDICAL CENTER   (United States)

^c NONE

Author keywords

Carmustine; Controlled release biodegradable polymer; Esthesioneuroblastoma; Gliadel ; Intracavitary chemotherapy; Local recurrence

Indexed keywords

CARMUSTINE; CISPLATIN; ETOPOSIDE;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CASE REPORT; CONTROLLED RELEASE FORMULATION; CRANIOTOMY; ESTHESIONEUROBLASTOMA; FEMALE; HEADACHE; HOSPITAL ADMISSION; HUMAN; LYMPH NODE METASTASIS; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MUSCLE WEAKNESS; NECK DISSECTION; NECK METASTASIS; NOSE SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; REOPERATION; TREATMENT OUTCOME; UNCONSCIOUSNESS;

ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; BIOCOMPATIBLE MATERIALS; CARMUSTINE; COMBINED MODALITY THERAPY; DECANOIC ACIDS; DRUG CARRIERS; DRUG IMPLANTS; ESTHESIONEUROBLASTOMA, OLFACTORY; FEMALE; HUMANS; NASAL CAVITY; NEOPLASM RECURRENCE, LOCAL; NOSE NEOPLASMS; POLYESTERS; TREATMENT OUTCOME;

EID: 33745056805     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-005-7411-y     Document Type: Article

References (27)

1. Berger L, Luc et Richard: L'esthesioneuroepitheliome olfactif. Bull Assoc Fr Etude Cancer 13: 410-421, 1924
2. P Dulguerov, AS Allal and TC Calcaterra, Esthesioneuroblastoma: A meta-analysis and review. Lancet Oncol 2 (2001) 683-690
3. PJ Bradley, NS Jones and I Robertson, Diagnosis and management of esthesioneuroblastoma. Curr Opin Otolayrngol Head Neck Surg 11 (2003) 112-118
4. P Sampath and H Brem, Implantable slow-release chemotherapeutic polymers for the treatment of malignant brain tumors. Cancer Control 5 (1998) 130-137
5. H Brem and P Gabikian, Biodegradable polymer implants to treat brain tumors. J Control Release 74 (2001) 63-67
6. Brem H, Piantadosi S, Burger PC, Walker M, Selker K, Vick NA, Black K, Sisti M, Brem S, Mohr G, Muller P, Morawetz R, Schold SC: For the polymer-brain tumor treatment group: Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The polymer-brain tumor treatment group. Lancet 345: 1008-1012, 1995
7. M Westphal, DC Hilt, E Bortey, P Delavault, R Olivares, PC Warnke, IR Whittle, J Jaaskelainen and Z Ram, A phase III trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel®) wafers) in patients with primary malignant glioma. Neuro-oncol 5 (2003) 79-88
8. ER Laws Jr, AM Morris and N Maartens, Gliadel for pituitary adenomas and craniopharyngiomas. Neurosurgery 53 (2003) 255-260
9. C Guerin, A Olivi, JD Weingart, HC Lawson and H Brem, Recent advances in brain tumor therapy: Local intracerebral drug delivery by polymers. Invest New Drugs 22 (2004) 27-37
10. JM Sheehan, JP Sheehan, JA Jane Sr and RS Polin, Chemotherapy for esthesioneuroblastomas. Neurosurg Clin of North Am 11 (2000) 693-701
11. K Watne and B Hager, Treatment of recurrent esthesioneuroblastoma with combined intra-arterial chemotherapy. A case report. J Neurooncol 5 (1987) 47-50
12. S Kadish, M Goodman and CC Wang, Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 37 (1976) 1571-1576
13. P Dulguerov and T Calcaterra, Esthesioneuroblastoma: The UCLA experience 1970-1990. Laryngoscope 102 (1992) 843-849
14. VJ Hyams, Olfactory neuroblastoma. In: VJ, Hyams, JG Baksakis and L Michaels (eds.) Tumors of the Upper Respiratory Tract and Ear. Washington DC: Armed Forces Institute of Pathology (1988) pp. 240-248
15. G Broich, A Pagliari and F Ottaviani, Esthesioneuroblastoma: A general review of the cases published since the discovery of the tumour in 1924. Anticancer Res 17 (1997) 2683-2706
16. A Morita, MJ Ebersold, KD Olsen, RL Foote, JE Lewis and LM Quast, Esthesioneuroblastoma: Prognosis and management. Neurosurgery 32 (1993) 706-715
17. HF Biller, W Lawson, VP Sachdev and P Som, Esthesioneuroblastoma: surgical treatment without radiation. Laryngoscope 100 (1990) 1199-1201
18. FL Dias, GM Sa, RA Lima, J Kligerman, MP Leoncio, EQ Freitas, JR Soares and RA Arcuri, Patterns of failure and outcome in esthesioneuroblastoma. Arch Otolaryngol Head Neck Surg 129 (2003) 1186-1192
19. D Elkon, SI Hightower, ML Lim, RW Cantrell and WC Constable, Esthesioneuroblastoma. Cancer 44 (1979) 1087-1094
20. BV Eden, RF Debo, JM Larner, MD Kelly, PA Levine, FM Stewart, RW Cantrell and WC Constable, Esthesioneuroblastoma. Long-term outcome and patterns of failure - the University of Virginia experience. Cancer 73 (1994) 2556-2562
21. PA Levine, R Gallagher and RW Cantrell, Esthesioneuroblastoma: reflections of a 21-year experience. Laryngoscope 109 (1999) 1539-1543
22. VA Resto, DW Eisele, A Forastiere, M Zahurak, DJ Lee and WH Westra, Esthesioneuroblastoma: The Johns Hopkins experience. Head Neck 22 (2000) 550-558
23. KS Chao, C Kaplan, JR Simpson, B Haughey, GJ Spector, DG Sessions and M Arquette, Esthesioneuroblastoma: The impact of treatment modality. Head Neck 23 (2001) 749-757
24. J Constantinidis, H Steinhart, M Koch, M Buchfelder, A Schaenzer, M Weidenbecher and H Iro, Olfactory neuroblastoma: The University of Erlangen-Nuremberg experience 1975-2000. Otolayrngol Head Neck Surg 130 (2004) 567-574
25. EA McElroy Jr., JC Buckner and JE Lewis, Chemotherapy for advanced esthesioneuroblastoma: The Mayo Clinic experience. Neurosurgery 42 (1998) 1023-1028
26. RS Polin, JP Sheehan, AG Chenell, E Munoz, J Larner, CD Phillips, RW Cantrell, ER Laws Jr, SA Newman, PA Levine and JA Jane, The role of preoperative adjuvant treatment in the management of esthesioneuroblastoma: The University of Virginia experience. Neurosurgery 42 (1998) 1029-1037
27. DW Kim, YH Jo, JH Kim, HG Wu, CS Rhee, CH Lee, TY Kim, DS Heo, YJ Bang and NK Kim, Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma. Cancer 101 (2004) 2257-2260